Results 111 to 120 of about 7,183 (232)
Humoral markers of endothelial dysfunction and systemic inflammatory response in patients with acute myocardial infarction depending on genes polymorphism of ACE (I/D) and eNOS (894G>T) [PDF]
The dynamics of endothelial dysfunction (ED) humoral factors: a soluble form of vascular cell adhesion molecule 1 (sVCAM-1), total NO metabolites and systemic inflammatory response - C-reactive protein (CRP) in patients with acute myocardial infarction
Biryuk, I.G. +5 more
core
Coronary artery disease is one of the leading causes of death globally. Despite the increased number of percutaneous coronary intervention (PCI) capable facilities, fibrinolytic therapy is still being utilized especially in rural areas.
Adham Mohamed PharmD +19 more
doaj +1 more source
Background: Tenecteplase is used as an alternative to alteplase and is considered noninferior for thrombolysis in acute ischemic stroke. Objectives: To compare the effectiveness and adverse effects of tenecteplase and alteplase in the real-world ...
Arpan Dutta +14 more
doaj +1 more source
Tenecteplase for Intravenous Thrombolysis of Ischemic Stroke: A Single MRI-based Comprehensive Stroke Center Experience [PDF]
Yongwoo Kim +7 more
openalex +1 more source
Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]
Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.) +3 more
core
Context This study will emphasise the importance of Tenecteplase being ideally suited as a first-choice drug for thrombolysis in AIS in developing countries, considering the numerous challenges which are faced in these parts of the world.
Neeraj Basantani +3 more
doaj +1 more source
Background The aim of this study was to investigate the efficacy and safety of tenecteplase versus alteplase in patients with acute ischemic stroke, considering their diabetes history and admission hyperglycemia status.
Huihui Liu +7 more
doaj +1 more source
Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns [PDF]
Yi Dong +3 more
openalex +1 more source
Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke
Background/Objectives: This study aims to compare the safety of tenecteplase versus alteplase for acute ischemic stroke. Methods: This was a multicenter, retrospective cohort study including 11 Memorial Hermann Health System hospitals in Houston from 7 ...
Salma Guerrero Miranda +4 more
doaj +1 more source
Чому атеросклероз однаково безжальний до судин мозку та серця? [PDF]
Рассмотрены современные представления об атеросклерозе с позиций определяющей роли нарушений липидного обмена и порождаемого ими воспалительного процесса. Обсуждается природа преимущественной клинической манифестации атеросклероза сосудов сердца и мозга.
Бичкова, О.Ю. +6 more
core

